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Abstract: In this paper, we evaluated the welfare effects of a hypothetical programme 
of Johne's disease eradication from the Scottish dairy herd on different stakeholders in 
the  domestic  milk  market.  We  undertook  the  evaluation  using  a  Markov-Chain 
simulation and applying an economic welfare analysis which takes into consideration 
the effects of an eradication programme on product price, on output quantity, on cost 
and on milk yield for given levels of supply and demand elasticities. We found that, 
following the eradication of the disease, milk yield per cow increased for all herd 
sizes in Scotland whereas price and unit cost of milk production fell. Consequently, 
milk  consumers  gained  around  £14.3  million  in  discounted  economic  surplus  and 
producers  with  infected  herds  around  £13.4  million  whereas  producers  with  un-
infected herds lost around £10.7 million in discounted surplus. The gain in surplus 
made by consumers and owners of infected herds, however, more than made up for 
the  loss  in  surplus  made  by  owners  of  un-infected  herds.  Therefore,  on  balance, 
Scotland gained a net economic surplus of £17 million from the programme.  
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1  Introduction 
Johne’s disease is a chronic bacterial infection that is widespread in domesticated and 
wild  ruminants.  The  infection  is  caused  by  Mycobacterium  avium  subsp. 
paratuberculosis (Mptb). The disease manifests itself as a chronic enteritis resulting in 
reduced  production,  weight  loss,  and  eventually  death.  The  clinical  signs  of  the 
disease do not show easily and it might take years before they are detected (Begg et 
al., 2005). In the UK, the herd and individual level prevalence rates are not known for 
certain. But from the small scale preliminary surveys that have been carried out, the 
prevalence rate within the dairy herd is estimated to be 17.5 % ±10% (Caldow and 
Gunn, 1999. 
 
The full economic cost of the disease in the UK dairy and beef herds is not very well 
known. This is not surprising given the difficulty involved in detecting the disease 
among dairy and beef herds. Bennett (1999), however, puts the cost of prevention and 
control of the disease in the range of £28.6 - £ 30.7 million. Caldow and Gunn (1999) 
estimate the annual losses due to paratuberculosis to be in the range of £4.2 to £15.4 
million for the dairy herd and in the range of £1.33 to £4.88 million for the beef herd.  
 
To date, no one has made an attempt to estimate the benefits accruing to producers 
and consumers of dairy products in the UK as a result of Johne's eradication. The 
study by Stott et al (2005) is an exception in that it estimates the benefit accruing to 
individual  dairy  farmers  in  the  wake  of  Johne's  eradication  from  the  dairy  herd. 
However, in essence, the study is a herd level analysis. As such, its focus is the farm 
and not the national level. Against this background, our paper is the first attempt at   3 
estimating  the  implications  of  Johne's  eradication  from  the  dairy  herd  for  the 
economic welfare of consumers and producers at the national level in Scotland.   
 
The  paper  is  outlined  as  follows.  Section  2  describes  the  aim  and  methodology. 
Section 3 describes the data used in the analysis. Section 4 discusses major results and 
their implications for policy. Finally, section 5 concludes. 
 
2  Aim and Methodology 
2.1  Economic model 
In  the  manner  of  other  similar  works  (Forsythe  and  Corso,  1994;  Ebel  et  al; 
Lichtenberg et al, 1988; and Andersson et al., 1997), the paper aims to achieve three 
objectives. Firstly, it calculates changes in the price and quantity of milk which result 
from Johne's eradication. At the conceptual level, these can be thought of as changes 
which result from improvements in epidemiological risk factors that contribute to the 
spread  of  Johne's  disease  (Losinger,  2006).  Secondly,  it  estimates  changes  in 
producers’ surplus for a category of farmers indirectly affected by the eradication 
programme.  These  are  farmers  whose  herds  are  free  of  the  disease  prior  to  the 
implementation of the programme. Thirdly, it estimates changes in producers’ surplus 
for a category of farmers whose herds are infected with Johne's disease before the 
implementation  of  the  programme.  Finally,  it  estimates  changes  in  consumers’ 
surplus. All through the analysis, the supply and demand functions are assumed to be 
approximately  linear  around  the  pre-eradication  equilibrium  where  the  price  and 
quantity changes are thought to be miniscule (Lichtenberg et al., 1988). By making 
this assumption, however we do not intend to ignore the importance of non linear 
demand and supply curves (Miller et al., 1988).    4 
  
Lichtenberg et al. (1988) are the first to offer a formal treatment of the theoretical 
model  on  which  this  analysis  is  based.  In  their  treatment,  they  first  describe  the 
equilibrium marginal cost functions for producers with infected herds and for those 
with  un-infected  herds,  the  equilibrium  market  demand  function,  and  the  market 
equilibrium quantity assuming that the market is perfectly competitive. They then 
describe  changes  in  market  price  and  in  quantity  following  the  introduction  of  a 
disease eradication programme assuming that the impact of such a programme on 
marginal cost is known. On the basis of estimates of changes in market price and in 
quantity,  they  then  estimate  the  effects  of  such  a  programme  on  changes  in 
consumers' and producers’ surpluses for given demand and supply functions.  
 
Following Forsythe and Corso (1994), given a reduction in price and an increase in 
quantity which result from disease eradication, changes in producers’ surplus (∆PS) 
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In (1), the term (P+dP) refers to the new equilibrium price of milk after eradication 
with  dP  denoting  the  reduction  in  price.  The  term  (Q+dQ)  represents  the  new 
equilibrium quantity of milk after eradication with dQ being the increase in quantity. 
The term (PQ) denotes revenue before eradication with P and Q being the base price 
and quantity supplied respectively. The term dC/Y is the reduction in cost (dC) per 
unit of output (Y) resulting from disease eradication. The term e  is the elasticity of   5 
supply. The terms PdQ and P(dQ)
2/2
ε Q
 denote the increase in the cost of production 
due to output expansion. The term, Qd, in (2) denotes the quantity of the product 
domestic consumers are willing to purchase at the given price.  
 
2.2  Empirical implementation 
2.2.1  Estimating price and quantity changes 
In order to calculate changes in the price and quantity of milk over a twenty-year 
horizon of the eradication program, the paper implemented an iterative procedure that 
takes  account  of  base  quantity  demanded  (or  supplied),  of  demand  and  supply 
elasticities and of changes in supply as a result of a small shift in marginal cost. This 
is  a  procedure  pioneered  by  Muth  (1964)  and  later  applied  by  Pinstrup-Andersen 
(1977) and by Alston and Scobie (1983), among others, to the analysis of  agricultural 
research benefits. The equations implemented in this procedure are as follows: 
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where  k=1,  2,...,  10  denotes  year  of  eradication  and  B= 
∆
S/Q
k-1  is  the  change  in 
quantity supplied, S, as a proportion of initial quantity in the previous period, Q
k-1 . 
The term 
ε  is as defined earlier whereas 
η  denotes the elasticity of demand in absolute 
value.   
 
The  change  in  supply  was  calculated  as  the  gain  in  milk  yield  per  infected  cow 
aggregated over the total number of infected cows in Scotland. This is calculated 
based on a Markov-Chain model developed from Stott et al (2005a). Base year milk 
quantity was calculated by first calculating the number of cows infected with the   6 
disease and then expressing this in terms of milk in litres based on yield generated 
from the aforementioned model. Quantity aggregation for the infected herd at the 
national  level  was  carried  out  assuming  that  the  yield  gain  from  the  hypothetical 
programme of eradication is uniform across the herd size distribution in Scotland. The 
implicit assumption is that herd size is not an important epidemiological risk factor in 
the spread of the disease. This assumption was based on a survey of veterinary experts 
in the field in Scotland (Stott et al., 2005b) and additional personal communication 
with experts in Europe. However, a minority of experts in the Scottish survey did rank 
herd size as an important risk factor in line with the position taken in the US where 
herd size distribution was identified as an epidemiological risk factor that impacts 
significantly on the spread of the disease (Losinger, 2006). However, in the absence 
of a clear indication of the extent of any herd size effect in Scotland, we maintained 
the  implicit  assumption  of  no  size  effect.  The  yield  gains  which  result  from  the 
eradication programme are calculated as the difference between yield per cow for the 
disease-free herd and that for the infected herd.  
 
2.2.2  Estimating cost changes 
The model based on Stott et al (2005a) was used to generate separate cost estimates 
for the infected and for the un-infected herds. These are estimates of variable costs 
associated with yield loss, with a longer calving interval, with lost future income, with 
culling, and with the treatment of clinical cases. On the basis of these cost estimates, 
the saving in unit cost of production per litre for the infected herd which resulted from 
the  eradication  programme  was  calculated.  This  was  done  by  calculating  the 
difference between unit variable cost for the infected herd and unit variable cost for 
the un-infected herd. We found that relative to a cow in a disease-free herd, a cow   7 
infected with Johne's cost £53/year more to maintain. This suggests that a programme 
aimed at eradicating the disease will increase the annuity which accrues to owners of 
the infected herd by this amount. In this calculation, the value of milk yield gained 
following Johne’s  eradication was assumed to  be one component of the cost that 
would otherwise have been incurred in the presence of the disease. However, in order 
to comply with the dictates of the economic model which we described in section 2.1, 
we treated the cost associated with milk yield loss saved following the programme of 
eradication as revenue gained rather than as a cost saved. This was done with no loss 
of generality to the analysis. In the following, the procedures used to calculate each of 
the cost components are detailed.  
 
Loss of milk yield: this was estimated assuming a Poisson distribution for the number 
of clinical cows in a herd and a Poisson or binomial distribution for the number of 
subclinical  cows.  The  yield  loss  was  converted  to  a  'cost'  using  the  method  of 
Benedictus et al (1987) which deducts 50% of concentrates saved from the proceeds 
of  milk  sale  assuming  that  clinical  cases  continue  to  eat  normally  but  eat  less 
concentrate as the yield drive to eat is reduced.  
 
Opportunity cost within lactation: this was estimated using a Markov  Chain. The 
major assumption in the calculation of this cost component was that the proportion of 
cows in each stage of the lactation curve and in the dry period were affected by 
Johne's. The Calving Interval (CI) was split into 4 equal periods (early, mid, late and 
dry). Using the assumed culling rates, the steady-state proportion of the herd in each 
period was estimated for clean and infected herds. Using a standard Woods curve 
(Wood, 1967) the effect of Johne's on the proportion of cows in each part of the curve   8 
over  a  CI  was  estimated.  This  was  considered  a  herd  level  effect  on  milk  yield 
(uninfected herd average) which was additional to the losses due to individual clinical 
and subclinical cows. Using a given CI, the result was expressed per year. Note that 
differential CIs for infected and uninfected herds was not currently allowed as CI was 
only used as a divisor to annualise results which would otherwise be calculated on a 
CI  basis.  Having  a  larger  divisor  for  infected  herds  might  result  in  a  smaller 
annualised  cost  than  for  clean  herds.  Effects  of  Johne's  disease  on  fertility  were 
therefore  not  accounted  for  except  as  increased  replacements.  This  seemed  a 
reasonable  assumption  to  make  as  all  clinical  cows  were  culled  under  default 
assumptions so their fertility was irrelevant and subclinical cows have 11% higher 
culling than normal (Benedictus et al., 1987). Additional allowances run the risk of 
double counting.   
 
Opportunity cost of prolonged dry period: idle production factors due to prolonged 
dry period were difficult to estimate using the methodology suggested by Benedictus 
et al. (1987). However, the relatively longer period of time an infected herd spent dry 
could be taken to be a lost opportunity. By calculating (for infected and for clean 
herds) the average yield opportunity lost per CI due to cows being dry and converting 
this to a lost yield per year and then to a lost gross margin, a comparison of the dry 
cow opportunity costs could be made. The use of a gross margin allowed that the lost 
production was offset by saved variable costs.  
 
Lost future income (between lactation opportunity cost): premature culling due to 
Johne's alters the herd age structure and hence the production potential of the herd due 
to  the  effect  of  lactation  number  on  yield.  Dynamic  programming  (DP)  adjusts   9 
voluntary replacement to minimise this effect. However, replacement decisions are 
not confined to milk yield and expected future Johne's risk. Farmers are therefore 
unlikely to follow such a policy even if they had the information. If they had a good 
test to detect Johne's, they would remove infected animals for their effect on herd 
mates even if the DP decision based on individual cow prospects was to keep. The 
alternative here is to predict long-run steady state herd age structures under fixed 
voluntary  and  involuntary  culling  proportions/probabilities  for  infected  and  clean 
herds (another Markov Chain) and use these to see the effect of age structure on clean 
herd average milk yield. The difference in gross margin based on this herd average 
milk yield difference was then the lost future income potential due to Johne's.  
 
Extra Involuntary culling costs: these were estimated based on the age structure of 
infected and clean herds from the Markov Chain used to calculate lost future income 
and based on involuntary culling rates by lactation number and by reasons for culling 
from the Kingshay Longevity report (Forbes et al., 1999). These data were converted 
into a number of cows culled in each lactation by reason for culling. Cows culled for 
infertility were sold at their maximum weight for age as predicted by the  cow growth 
model of Van Arendonk (1985). Other reasons for culling yielded average weights for 
age as culled cows are not assured of completing lactation and so gaining weight 
before sale. For infected herds, extra cows were culled due to additional involuntary 
culling  of  clinical  and  subclinical  cows.  Subclinical  cows  were  culled  at  average 
weight for age, whereas clinical cows were culled at minimum. This gave an average 
weight loss for clinical cows over subclinical cows of 79kg (compared to 100kg in 
Benedictus et al., 1987). 
   10 
Extra Voluntary culling costs: these were calculated based on age structure as for 
involuntary culling. Any costs in the default settings were due solely to differences in 
age structure of the herd as voluntary culling rates and values of culls were identical.  
 
Veterinary costs of clinical cases were assumed to be £100 per clinical case by default 
as in Stott et al (2005a). 
 
3  Data description 
The cost data used in this analysis were estimates of the cost of a standard Johne's 
epidemic in dairy herds generated by a Markov Chain model as described above for a 
100-cow dairy herd in Scotland. An all-year farm-gate milk price of 17.58 pence per 
litre (ppl) was used as a base price (SAC, 2006, p.133). A long run milk supply 
elasticity of 1.8 was used (Colman et al., 2005). A milk demand elasticity of -0.17 
was used (National Food Survey, 2000). A herd prevalence rate of 0.27 for Johne's 
was used to calculate the proportion of infected herds in Scotland (Stott et al., 2005a). 
This represented the proportion of herds with clinical (0.02) and sub-clinical cases 
(0.25).  A discount rate of 3.5% used to calculate the net present value of benefits was 
obtained from the Government Green Book (HM Treasury, 2007). 
 
4  Results and discussion  
4.1  Price and quantity effects 
As a consequence of Johne's eradication, the price of milk steadily declined at the rate 
of 0.7% per annum whereas aggregate quantity of milk produced increased at the rate 
of 1.9% per annum. Yield among infected herds increased by 187 litres per cow per 
annum whereas unit cost declined by 0.35 pence per litre per annum (Table 1).    11 
Table 1 
Parameter values and their distribution between herd types, Scottish dairy 
in the presence of Johne's disease 
Parameter  Infected   Uninfected  Difference  
Yield (in litres/cow)  6015.00  6202.00  187 
Unit cost (pence/litre)           -0.36 
Herd  size  (Number  of 
cows per farm) 
Scottish  dairy  herd 
('000  cows  and  heifers 
in milk)









     





125.39   
*SEERAD,2006 
4.2  Distributional consequences of Johne's eradication  
Following the eradication of Johne's disease from the Scottish dairy herd, consumers 
gained around £ £14.3  million in discounted surplus whereas owners of the infected 
herd gained around £13.4  million in such surplus. Owners of the uninfected herd, on 
the  other  hand,  lost  £10.7  million  in  discounted  surplus.  On  net,  the  eradication 
programme generated around £17 million in net economic gain for Scotland (Table 
3). In a similar exercise, Losinger (2006) finds similar results for the US dairy sector 
except that he is not conclusive about whether Johne's positive operations gain from 
an eradication program. In the light of our analysis, the reason his model does not 
come up with a positive economic gain for Johne's positive operations is because he 
does  not  take  account  of  the  cost  saving  which  such  operations  make  following 
eradication.  
 
Table 3 also presents the sensitivity of net economic surplus to changes in supply and 
demand elasticities. The major result is that net economic benefits decline as demand 




   12 
Table 2  
The sensitivity of net economic surplus changes for the Scottish  
dairy herd assuming ranges of values for the demand elasticity  








4.3  Discussion of results  
The reason producers with infected herds gain in surplus is that a programme of 
Johne's eradication brings about a unit cost saving which is greater than the unit price 
reduction which the same programme brings about. The reason producers with un-
infected herds lose in surplus over the said period is that, for a given unit cost of 
production, quantity of milk increases with the result that price of milk per litre falls.  
 
The reason consumers gain in surplus can be explained as follows. On the one hand, 
the eradication programme results in a unit cost reduction for the affected farmers. 
On the other hand, such a programme increases the quantity of milk produced. Both 
effects  push  the  price  of  milk  down.  Consequently,  consumers  benefit  from  an 
increase in surplus relative to their position prior to Johne's eradication.  
 
On  balance,  the  eradication  programme  has  a  positive  impact  on  net  economic 
surplus for Scotland. This is because the increase in combined economic surpluses 
ε   
η =0.2 
η  =0.4 
η  =0.6 
η  =0.8 
1.8  17.00  17.40  17.90  18.50 
2  16.58  16.86  17.20  17.70 
3  15.81  15.92  16.00  16.20 
4  15.43  15.49  15.60  15.60 
5  15.21  15.25  15.29  15.30 
6  15.07  15.09  15.11  15.15 
7  14.96  14.98  15.00  15.02 
8  14.89  14.90  14.91  14.93 
9  14.83  14.84  14.85  14.86 
10  14.78  14.79  14.80  14.81   13 
accruing to consumers and to producers of the infected herd more than offset the 
reduction in producers’ surplus for the un-infected herd.  
 
The  above  results  need  to  be  treated  with  caution  taking  account  of  the  model's 
restrictive assumptions. Firstly, it assumes that demand and supply elasticities remain 
constant throughout the eradication period. Secondly, it assumes away international 
trade effects. In other words, it assumes that not only will the level of imported milk 
supply  remain  unchanged  but  increased  domestic  supply  of  milk  will  affect  only 
domestic milk price and not international milk price. Thirdly, it does not take account 
of other epidemiological effects. For instance, it does not allow for the possibility of 
another disease filling the vacuum left by Johne's. Finally, it does not take account of 
the on-going costs of keeping the disease out, the cost of getting rid of the disease in 
the  first  place  and  of  increasing  marginal  costs  of  eradication  as  the  eradication 
programme progresses. Despite the restriction they place on the model, nevertheless, 
these assumptions are essential in order to carry out analysis of this type as they 
isolate  the  particular  impact  of  eradication  on  price  and  quantity.  Our  analysis 
assesses  the  ceteris  paribus  position  as  a  necessary  starting  point  for  further 
evaluation. For example, it gives an idea of the opportunity cost to the nation of 
failure to instigate an eradication programme. This can then be compared with the 
expected costs of carrying out such a programme.   
 
Our hypothetical Johne's eradication programme in the Scottish dairy herd is assumed 
to be carried out independently of a similar programme in the Scottish beef herd. 
Given that, geographically, the two systems exist in close proximity to each other it 
would not be long before the disease made its way back from the beef herd to the   14 
dairy herd if no programme were implemented in the beef herd. This may render the 
now free and naive dairy herd more susceptible to re-infection. With the view to 
controlling  for  such  effects,  we  assumed  that  the  aforementioned  eradication 
programme was implemented in both the dairy and beef systems simultaneously. 
 
Thus far, the implicit assumption has been that the eradication programme eliminates 
the epidemiological risk-factors which contribute to the spread of Johne’s disease all 
at once. Such risk factors might include size of dairy herd per farm, geographical 
location  of  a  farm,  percentage  of  cows  not  born  on  the  operation,  multiple-cow-
maternity housing used in a previous year and multiple-preweaned-calf housing used 
in previous year to name just a few (Losinger, 2006, 2005). Given that some risk 
factors are easier to eliminate than others it is unrealistic to assume that all of them 
will  be  eliminated  at  once.  A  more  meaningful  approach  to  an  evaluation  of  a 
programme of Johne's disease eradication from the Scottish dairy herd is therefore to 
calculate  "the  fraction  of  Johne's  disease  that  can  be  prevented  by  eliminating 
exposure of the herd to a specific categorical risk factor from a population, while the 
distribution of other risk factors in the population remains constant" (Losinger, 2006, 
p.33).  
 
In  epidemiology  parlance,  the  aforementioned  fraction  is  called  the  population-
attributable-fraction (PAF) (Bruzzi, et al., 1985; Rockhill et al, 1988). It has been in 
wide use in human medicine and is calculated from a logistic-regression model which 
calculates categorical risk factors associated with Johne's disease on dairy operations 














p PAF i i b
b 1
 
where PAFi is the population-attributable fraction, 
β i is the coefficient derived from 
the logistic-regression model, and pi is the proportion of cases for the i-th category of 
a categorical risk factor. The logistic-regression model coefficients, and the associated 
proportion  of  Johne's-positive  operations  are  parameters  that  are  supplied  by 
epidemiologists based on data generated by scientists working in the field. For the 
base category, (i=1), 
β 1=0, e
β 1=1 and the PAFi=0. For categories other than the base 
category,  PAFi  indicates  the  fraction  of  disease  that  can  be  prevented  by  shifting 
everyone in a particular category to the base category of the risk factor. 
 
Once the fraction for each categorical variable is known, then the benefits and costs of 
a Johne's eradication programme that can be attributed to each categorical variable are 
easy  to  reckon.  This  involves  multiplying  changes  in  consumers'  and  producers' 
surpluses by the PAF corresponding to each particular risk factor. To our knowledge 
no  one  has  made  an  attempt  to  estimate  the  economic  welfare  impact  of  Johne's 
eradication  resulting  from  eliminating  exposure  of  the  dairy  herd  to  a  particular 
epidemiological risk factor.  At the moment, however, we have found no such PAFs 
published for Johne's in the UK. 
 
4.4  Policy implications 
As  the  above  analysis  showed,  a  programme  of  Johne's  eradication  favoured 
consumers and milk producers with infected herds at the expense of producers with 
un-infected herds. Clearly, on consideration of the favourable economic implications 
of  the  programme,  it  is  reasonable  to  expect  that  it  will  be  popular  among  dairy   16 
farmers  whose  herds  are  currently  being  affected  by  Johne's.  However,  the 
programme might not garner support among producers whose herds are currently free 
of the disease as they stand to lose their comparative advantage. But given that living 
with  Johne's  (or  any  endemic  disease)  involves  the  risk  of  a  financial  loss 
considerably  greater  than  expected  losses,  farmers  who  are  currently  disease-free 
might prefer eradication even if the expected net benefits are inferior to living with 
the disease to the extent that eradication reduces production risks (Oglethorpe, 1995). 
There are, however, several other non-economic considerations which can be used to 
elicit farmers’ support for such an eradication programme.  
 
Firstly, the ethics of good farming requires that farmers rear a disease-free stock able 
to produce milk which consumers trust. 
 
Secondly,  animal  welfare  policies  require  that  animals  be  treated  as  humanely  as 
possible and that they do not suffer the avoidable effects of any disease. For instance, 
one of the “Five Freedoms”, which underlie the basic principles of the Farm Animal 
Welfare Council (FAWC) of Britain, stipulates that “animals be free from pain, injury 
and disease through prevention, rapid diagnosis and treatment”. At the moment the 
Five Freedoms are serving as a benchmark for evaluating animal welfare standards 
only for such limited farm schemes as Farm Assurance and Organic Certification. 
However, it is only a matter of time before they permeate through all other schemes of 
farming.  
 
Thirdly,  food  retailers  and  consumers  are  becoming  more  critical  of  the  welfare 
dimension of animal products when making their purchase decisions. On the face of   17 
this, producers of primary products cannot afford to be lax in the health and welfare 
standard expected of their stock. It suffices to invoke the recent crisis related to BSE 
to realize how much the breakout of a health scare anywhere in the food supply chain 
can lessen consumers’ trust in the safety of the food they eat.  
 
Fourthly,  if  competitor  countries  make  more  progress  in  reducing  or  eliminating 
Johne’s  disease  Scottish  dairy  products  traded  in  the  world  market  may  earn  a 
negative  image  particularly  if  Scotland  does  not  show  as  strong  commitment  to 
eradication.  Given  the  potential  negative  impact  that  this  image  can  have  on 
Scotland’s dairy trade with other European countries, Scottish farmers’ participation 
in a Johne's eradication programme works to their own long term advantage even if 
the cost of the eradication programme is borne by themselves.  
 
To this stage, the paper has brushed aside the issue of who pays for the cost of the 
proposed  Johne's  eradication  programme.  The  most  recent  government  policy  on 
animal health (Defra et al., 2004) seems to advocate that the cost burden of disease 
prevention and control be borne more by owners of farm animals themselves rather 
than  by  taxpayers.  As  this  analysis  has  shown,  however,  most  of  the  benefits  of 
Johne's disease eradication in Scotland accrue to consumers and to owners of infected 
herds in Scotland. It may therefore be argued that the cost of such an eradication 
programme be shared between consumers and owners of infected dairy herds rather 
than be borne fully by all farmers. If results regarding the distribution of benefits were 
to provide a rough guide as to the amount domestic actors involved need to contribute 
to Johne's eradication, it appears that consumers and producers with infected herds   18 
should pay the greater proportion of the cost of eradication. This is in keeping with 
the "beneficiary pays principle" being advocated by the Government (Defra, 2007).  
 
5   Conclusions 
In  this  paper,  we  attempted  to  estimate  changes  in  consumers’  and  producers’ 
surpluses in the Scottish dairy herd following Johne's eradication assuming a 20-year 
Johne's  eradication  programme.  We  found  that  as  a  result  of  the  eradication 
programme,  consumers  and  farmers  with  infected  herds  made  a  positive  gain  in 
surplus whereas farmers with un-infected herds made a loss in surplus. However, the 
economic surplus gained by consumers and farmers with infected herds more than 
made  up  for  the  loss  in  surplus  made  by  producers  with  un-infected  herds.  On 
balance,  therefore,  the  eradication  programme  generated  a  net  positive  economic 
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